Cargando…
New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis
The emergence of the new pathogen SARS-CoV-2 determined a rapid need for monoclonal antibodies (mAbs) to detect the virus in biological fluids as a rapid tool to identify infected individuals to be treated or quarantined. The majority of commercially available antigenic tests for SARS-CoV-2 rely on...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953266/ https://www.ncbi.nlm.nih.gov/pubmed/36831149 http://dx.doi.org/10.3390/biomedicines11020610 |
_version_ | 1784893835537547264 |
---|---|
author | Mariotti, Sabrina Chiantore, Maria Vincenza Teloni, Raffaela Iacobino, Angelo Capocefalo, Antonio Michelini, Zuleika Borghi, Martina Baggieri, Melissa Marchi, Antonella Bucci, Paola Gioacchini, Silvia D’Amelio, Raffaele Brouwer, Philip J. M. Sandini, Silvia Acchioni, Chiara Sgarbanti, Marco Di Virgilio, Antonio Grasso, Felicia Cara, Andrea Negri, Donatella Magurano, Fabio Di Bonito, Paola Nisini, Roberto |
author_facet | Mariotti, Sabrina Chiantore, Maria Vincenza Teloni, Raffaela Iacobino, Angelo Capocefalo, Antonio Michelini, Zuleika Borghi, Martina Baggieri, Melissa Marchi, Antonella Bucci, Paola Gioacchini, Silvia D’Amelio, Raffaele Brouwer, Philip J. M. Sandini, Silvia Acchioni, Chiara Sgarbanti, Marco Di Virgilio, Antonio Grasso, Felicia Cara, Andrea Negri, Donatella Magurano, Fabio Di Bonito, Paola Nisini, Roberto |
author_sort | Mariotti, Sabrina |
collection | PubMed |
description | The emergence of the new pathogen SARS-CoV-2 determined a rapid need for monoclonal antibodies (mAbs) to detect the virus in biological fluids as a rapid tool to identify infected individuals to be treated or quarantined. The majority of commercially available antigenic tests for SARS-CoV-2 rely on the detection of N antigen in biologic fluid using anti-N antibodies, and their capacity to specifically identify subjects infected by SARS-CoV-2 is questionable due to several structural analogies among the N proteins of different coronaviruses. In order to produce new specific antibodies, BALB/c mice were immunized three times at 20-day intervals with a recombinant spike (S) protein. The procedure used was highly efficient, and 40 different specific mAbs were isolated, purified and characterized, with 13 ultimately being selected for their specificity and lack of cross reactivity with other human coronaviruses. The specific epitopes recognized by the selected mAbs were identified through a peptide library and/or by recombinant fragments of the S protein. In particular, the selected mAbs recognized different linear epitopes along the S1, excluding the receptor binding domain, and along the S2 subunits of the S protein of SARS-CoV-2 and its major variants of concern. We identified combinations of anti-S mAbs suitable for use in ELISA or rapid diagnostic tests, with the highest sensitivity and specificity coming from proof-of-concept tests using recombinant antigens, SARS-CoV-2 or biological fluids from infected individuals, that represent important additional tools for the diagnosis of COVID-19. |
format | Online Article Text |
id | pubmed-9953266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99532662023-02-25 New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis Mariotti, Sabrina Chiantore, Maria Vincenza Teloni, Raffaela Iacobino, Angelo Capocefalo, Antonio Michelini, Zuleika Borghi, Martina Baggieri, Melissa Marchi, Antonella Bucci, Paola Gioacchini, Silvia D’Amelio, Raffaele Brouwer, Philip J. M. Sandini, Silvia Acchioni, Chiara Sgarbanti, Marco Di Virgilio, Antonio Grasso, Felicia Cara, Andrea Negri, Donatella Magurano, Fabio Di Bonito, Paola Nisini, Roberto Biomedicines Article The emergence of the new pathogen SARS-CoV-2 determined a rapid need for monoclonal antibodies (mAbs) to detect the virus in biological fluids as a rapid tool to identify infected individuals to be treated or quarantined. The majority of commercially available antigenic tests for SARS-CoV-2 rely on the detection of N antigen in biologic fluid using anti-N antibodies, and their capacity to specifically identify subjects infected by SARS-CoV-2 is questionable due to several structural analogies among the N proteins of different coronaviruses. In order to produce new specific antibodies, BALB/c mice were immunized three times at 20-day intervals with a recombinant spike (S) protein. The procedure used was highly efficient, and 40 different specific mAbs were isolated, purified and characterized, with 13 ultimately being selected for their specificity and lack of cross reactivity with other human coronaviruses. The specific epitopes recognized by the selected mAbs were identified through a peptide library and/or by recombinant fragments of the S protein. In particular, the selected mAbs recognized different linear epitopes along the S1, excluding the receptor binding domain, and along the S2 subunits of the S protein of SARS-CoV-2 and its major variants of concern. We identified combinations of anti-S mAbs suitable for use in ELISA or rapid diagnostic tests, with the highest sensitivity and specificity coming from proof-of-concept tests using recombinant antigens, SARS-CoV-2 or biological fluids from infected individuals, that represent important additional tools for the diagnosis of COVID-19. MDPI 2023-02-18 /pmc/articles/PMC9953266/ /pubmed/36831149 http://dx.doi.org/10.3390/biomedicines11020610 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mariotti, Sabrina Chiantore, Maria Vincenza Teloni, Raffaela Iacobino, Angelo Capocefalo, Antonio Michelini, Zuleika Borghi, Martina Baggieri, Melissa Marchi, Antonella Bucci, Paola Gioacchini, Silvia D’Amelio, Raffaele Brouwer, Philip J. M. Sandini, Silvia Acchioni, Chiara Sgarbanti, Marco Di Virgilio, Antonio Grasso, Felicia Cara, Andrea Negri, Donatella Magurano, Fabio Di Bonito, Paola Nisini, Roberto New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis |
title | New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis |
title_full | New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis |
title_fullStr | New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis |
title_full_unstemmed | New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis |
title_short | New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis |
title_sort | new monoclonal antibodies specific for different epitopes of the spike protein of sars-cov-2 and its major variants: additional tools for a more specific covid-19 diagnosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953266/ https://www.ncbi.nlm.nih.gov/pubmed/36831149 http://dx.doi.org/10.3390/biomedicines11020610 |
work_keys_str_mv | AT mariottisabrina newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT chiantoremariavincenza newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT teloniraffaela newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT iacobinoangelo newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT capocefaloantonio newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT michelinizuleika newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT borghimartina newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT baggierimelissa newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT marchiantonella newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT buccipaola newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT gioacchinisilvia newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT damelioraffaele newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT brouwerphilipjm newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT sandinisilvia newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT acchionichiara newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT sgarbantimarco newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT divirgilioantonio newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT grassofelicia newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT caraandrea newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT negridonatella newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT maguranofabio newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT dibonitopaola newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis AT nisiniroberto newmonoclonalantibodiesspecificfordifferentepitopesofthespikeproteinofsarscov2anditsmajorvariantsadditionaltoolsforamorespecificcovid19diagnosis |